314 related articles for article (PubMed ID: 19010781)
1. Conformational diversity of wild-type Tau fibrils specified by templated conformation change.
Frost B; Ollesch J; Wille H; Diamond MI
J Biol Chem; 2009 Feb; 284(6):3546-51. PubMed ID: 19010781
[TBL] [Abstract][Full Text] [Related]
2. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M
J Biol Chem; 2018 Nov; 293(45):17336-17348. PubMed ID: 30242125
[TBL] [Abstract][Full Text] [Related]
3. The Lys 280 → Gln mutation mimicking disease-linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties.
Kumar H; Udgaonkar JB
Protein Sci; 2021 Apr; 30(4):785-803. PubMed ID: 33496017
[TBL] [Abstract][Full Text] [Related]
4. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias.
Barghorn S; Zheng-Fischhöfer Q; Ackmann M; Biernat J; von Bergen M; Mandelkow EM; Mandelkow E
Biochemistry; 2000 Sep; 39(38):11714-21. PubMed ID: 10995239
[TBL] [Abstract][Full Text] [Related]
5. Fibrillization of human tau is accelerated by exposure to lead via interaction with His-330 and His-362.
Zhu HL; Meng SR; Fan JB; Chen J; Liang Y
PLoS One; 2011; 6(9):e25020. PubMed ID: 21966400
[TBL] [Abstract][Full Text] [Related]
6. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
7. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
8. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
[TBL] [Abstract][Full Text] [Related]
9. Alpha-helix structure in Alzheimer's disease aggregates of tau-protein.
Sadqi M; Hernández F; Pan U; Pérez M; Schaeberle MD; Avila J; Muñoz V
Biochemistry; 2002 Jun; 41(22):7150-5. PubMed ID: 12033949
[TBL] [Abstract][Full Text] [Related]
10. Trans-cellular propagation of Tau aggregation by fibrillar species.
Kfoury N; Holmes BB; Jiang H; Holtzman DM; Diamond MI
J Biol Chem; 2012 Jun; 287(23):19440-51. PubMed ID: 22461630
[TBL] [Abstract][Full Text] [Related]
11. Granular tau oligomers as intermediates of tau filaments.
Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
[TBL] [Abstract][Full Text] [Related]
12. Structurally Distinct Polymorphs of Tau Aggregates Revealed by Nanoscale Infrared Spectroscopy.
Banerjee S; Ghosh A
J Phys Chem Lett; 2021 Nov; 12(45):11035-11041. PubMed ID: 34747175
[TBL] [Abstract][Full Text] [Related]
13. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
[TBL] [Abstract][Full Text] [Related]
14. Competing interactions stabilize pro- and anti-aggregant conformations of human Tau.
Wegmann S; Schöler J; Bippes CA; Mandelkow E; Muller DJ
J Biol Chem; 2011 Jun; 286(23):20512-24. PubMed ID: 21498513
[TBL] [Abstract][Full Text] [Related]
15. Tau aggregation is driven by a transition from random coil to beta sheet structure.
von Bergen M; Barghorn S; Biernat J; Mandelkow EM; Mandelkow E
Biochim Biophys Acta; 2005 Jan; 1739(2-3):158-66. PubMed ID: 15615635
[TBL] [Abstract][Full Text] [Related]
16. The structure and phase of tau: from monomer to amyloid filament.
Zeng Y; Yang J; Zhang B; Gao M; Su Z; Huang Y
Cell Mol Life Sci; 2021 Mar; 78(5):1873-1886. PubMed ID: 33078207
[TBL] [Abstract][Full Text] [Related]
17. Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau.
Aoyagi H; Hasegawa M; Tamaoka A
J Biol Chem; 2007 Jul; 282(28):20309-18. PubMed ID: 17526496
[TBL] [Abstract][Full Text] [Related]
18. In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments.
Dregni AJ; Mandala VS; Wu H; Elkins MR; Wang HK; Hung I; DeGrado WF; Hong M
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16357-16366. PubMed ID: 31358628
[TBL] [Abstract][Full Text] [Related]
19. Cofactors are essential constituents of stable and seeding-active tau fibrils.
Fichou Y; Lin Y; Rauch JN; Vigers M; Zeng Z; Srivastava M; Keller TJ; Freed JH; Kosik KS; Han S
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13234-13239. PubMed ID: 30538196
[TBL] [Abstract][Full Text] [Related]
20. Tau P301L mutation promotes core 4R tauopathy fibril fold through near-surface water structuring and conformational rearrangement.
Vigers MP; Lobo S; Najafi S; Dubose A; Tsay K; Ganguly P; Longhini AP; Jin Y; Buratto SK; Kosik KS; Shell MS; Shea JE; Han S
bioRxiv; 2023 Nov; ():. PubMed ID: 38077065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
